期刊文献+

蛋白磷酸酶2A的癌性抑制因子表达对喉癌细胞株Hep-2增殖的影响及相关机制研究 被引量:2

Effects of cancerous inhibitor of protein phosphatase 2A expression on proliferation of laryngeal squamous cell carcinomas cell Hep-2 and its mechanism
下载PDF
导出
摘要 目的:研究蛋白磷酸酶2A的癌性抑制因子(cancerous inhibitor of protein phosphatase 2A,CIP2A)表达对喉癌细胞株Hep-2增殖的影响及相关分子机制。方法:以特异性si RNA和阴性对照序列转染喉癌Hep-2细胞,实验分为CIP2A si RNA组与Control si RNA组。平板克隆形成实验检测CIP2A在喉癌细胞增殖中的作用;MTT法检测CIP2A对细胞生长曲线及顺铂敏感性影响;流式细胞术检测细胞周期分布和凋亡率的改变。real-time PCR检测CIP2A m RNA表达水平,Western blot检测CIP2A及生长相关蛋白c-myc、AKT、p-AKT、cyclin D1的蛋白表达水平。结果:沉默CIP2A后,CIP2A在基因及蛋白水平的表达量明显降低,Hep-2细胞生长减缓,克隆的形成被抑制,Control si RNA组为339.00±34.00,CIP2A si RNA组为126.00±33.00,差异有统计学意义(t=-7.796,P=0.010);沉默CIP2A可增加喉癌细胞对顺铂的敏感性,Control si RNA组IC50为(6.67±0.54)μg/ml,CIP2A si RNA组为(3.53±0.32)μg/ml,差异有统计学意义(t=8.598,P=0.001);细胞周期阻滞于G1期,Control si RNA组G1期细胞比例为66.860±1.972,CIP2A si RNA组为74.613±3.357,差异有统计学意义(t=3.449,P=0.026);S期细胞比例减少,Control si RNA组为23.713±1.564,CIP2A si RNA组为17.747±1.255,差异有统计学意义(t=-5.153,P=0.007);沉默CIP2A没有引起细胞凋亡率的变化(P=0.216)。Western blot结果显示,沉默CIP2A表达可下调Cyclin D1(t=-4.531,P=0.011)、c-myc(t=-4.522,P=0.011)、pAKT(t=-4.574,P=0.010)的表达,但对总AKT蛋白的表达没有影响(t=0.051,P=0.962)。结论:沉默CIP2A基因可抑制喉癌Hep-2细胞生长,增加喉癌细胞对顺铂的敏感性,其机制可能与下调c-myc、p-AKT、cyclin D1的表达有关。 Objective:To investigate the effects of cancerous inhibitor of protein phosphatase 2A(CIP2A)expression on proliferation of laryngeal squamous cell carcinomas cells Hep-2 and its mechanism. Methods:si RNA-mediated CIP2 A and negative control sequences were performed in Hep-2 cells. The experiment was designed into CIP2 A si RNA group and control si RNA group. Colony formation assay was used to examine the role of CIP2 A in cell proliferation. The impact of CIP2 A on cell growth and cisplatin sensitivity was evaluated using MTT assay. Flow cytometry was used to examine cell cycle distribution and apoptotic rate. Quantitative real-time PCR and Western blot were applied to assess the expression of CIP2 A,c-myc,AKT,p-AKT,and cyclin D1. Results:CIP2A knockdown in Hep-2 cells markedly decreased both CIP2 A m RNA and protein expression,reduced the proliferation speed and colony formation(P=0.010)and increased the drug sensitivity of the cells to cisplatin(P=0.001). In addition,CIP2 A depletion blocked cell cycle at G1phase(P=0.026)and decreased the percentage of S stage cells(P=0.007),and did not significantly alter cell apoptosis rate(P=0.216).Western blot showed that CIP2 A depletion downregulated Cyclin D1,c-myc,p-AKT expression(P=0.011,P=0.011,P=0.010),but had no effects on the expression of total AKT protein(P =0.962).Conclusion:CIP2A depletion inhibits cell proliferation and increases the sensitivity to cisplatin,mechanism of which may be related with decreased c-myc,p-AKT,and cyclin D1.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2015年第3期431-435,共5页 Journal of Chongqing Medical University
基金 重庆市自然科学基金资助项目(编号:cstc2013jcyj A10059) 国家临床重点专科建设经费资助项目(卫办医改函[2012]649号)
关键词 喉肿瘤 蛋白磷酸酶2A的癌性抑制因子 SI RNA 药物敏感性 增殖 凋亡 laryngeal squamous cell carcinoma cancerous inhibitor of protein phosphatase 2A si RNA drug sensitivity proliferation apoptosis
  • 相关文献

参考文献18

  • 1Ferlay J ,Shin HR,Bray F ,et al.Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008[J].Int J Cancer,2010,127(l2): 2893-2917.
  • 2Junttila MR,Puustinen P,Niemela M,et al.CIP2A inhibits PP2A in human malignancies[J] .Cell, 2007 , 130(1 ) : 51-62.
  • 3Ma L, Wen ZS,Liu Z,et al.Overexpression and small molecule-trig?gered downregulation of CIP2A in lung cancer[J].PLoS ONE ,2011 ,6 (5) :e20159.
  • 4Bockelman C,Lassus H,Hemmes A,et al.Prognostic role of CIP2A expression in serous ovarian cancer[J].Br J Cancer ,2011,105(7) :989- 995.
  • 5Ren J ,Li W, Yan L,et al.Expression of CIP2A in renal cell carci?nomas correlates with tumour invasion, metastasis and patients survival[J].Br J Cancer ,2011,105(12): 1905-1911.
  • 6Zhai M,Cong L,Han Y,et al.CIP2A is overexpressed in osteosar?coma and regulates cell proliferation and invasion[J].Tumour Biol,2014, 35(2):1123-1128.
  • 7Wang L, Gu F, Ma N, et al.CIP2A expression is associated with al?tered expression of epithelial-mesenchymal transition markers and pre?dictive of poor prognosis in pancreatic ductal adenocarcinoma[J].Tu?mour Bioi, 2013, 34( 4) : 2309-2313.
  • 8Came C,Laine A,Chanrion M,et al.CIP2A is associated with hu?man breast cancer aggressivity[J].Clin Canc Res ,2009 , 15 (16) :5092- 5100.
  • 9Teng HW, Yang SH,Lin JK,et al.CIP2A is a predictor of poor prog?nosis in colon cancer[J].J Gastrointest Surg, 2012 , 16(5): 1037-1047.
  • 10Khanna A,Bockelman C,Hemmes A,et al.MYC-dependent reg?ulation and prognostic role of CIP2A in gastric cancer[J].J Natl Cancer Inst, 2009 , 101 (11): 793-805.

二级参考文献52

  • 1Mumby M. PP2A: unveiling a reluctant tumor suppressor. Cell 2007; 130:21-24.
  • 2Janssens v, Goris J, Van Hoof C. PP2A: the expected tumor suppressor. Curr Opin Genet Dev 2005; 15: 34-41.
  • 3Junttila MR, Puustinen P, Niemela M, Ahola R, Arnold H, Bottzauw T, Ala-aho R, Nielsen C,Ivaska J, Taya Y, Lu SL, Lin S, Chan EK, Wang XJ, Grenman R, Kast J, Kallunki T, Sears R, Kahari VM, Westermarck J. CIP2A inhibits PP2A in human malignancies. Cell 2007; 130:51-62.
  • 4Nagase T, Kikuno R, Ohara O. Prediction of the coding sequences of unidentified human genes. ⅩⅫ. The complete sequences of 50 new cDNA clones which code for large proteins. DNA Res 2001; 8:319-327.
  • 5Soo Hoo L, Zhang JY, Chan EK. Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer. Oncogene 2002; 21:5006-5015.
  • 6Janssens V, Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 2001; 353:417-439.
  • 7Schonthal AH. Role of serine/threonine protein phosphatase 2A in cancer. Cancer Lett 2001; 170: 1-13.
  • 8Sears R, Leone G, DeGregori J, Nevins JR. Ras enhances Myc protein stability. Mol Cell 1999; 3: 169-179.
  • 9Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev 2000; 14:2501-2514.
  • 10Arnold HK, Sears RC. Protein phosphatase 2A regulatory subunit B56alpha associates with c-myc and negatively regulates c-myc accumulation. Mol Cell Biol 2006; 26:2832-2844.

共引文献31

同被引文献20

  • 1廖燕.乳腺癌易感基因BRCA1的研究进展[J].基层医学论坛,2006,10(2):176-176. 被引量:2
  • 2Farrell AS,Allen-Petersen B,Daniel CJ,et al.Targeting inhibitors of the tumor suppressor PP2Afor the treatment of pancreatic cancer[J].Mol Cancer Res,2014,12(6):924-939.
  • 3Tsuchiya A,Kanno T,Shimizu T,et al.A novel PP2Aenhancer induces caspase-independent apoptosis of MKN28gastric cancer cells with high MEK activity[J].Cancer Lett,2014,347(1):123-128.
  • 4Janghorban M,Farrell AS,Allen-Petersen BL,et al.Targeting cMYC by antagonizing PP2Ainhibitors in breast cancer[J].ProcNatlAcadSci U S A,2014,111(25):9157-9162.
  • 5Liu Z,Ma L,Wen ZS,et al.Ethoxysanguinarine Induces Inhibitory Effects and Downregulates CIP2Ain Lung Cancer Cells[J].ACS Med Chem Lett,2013,5(2):113-118.
  • 6Fujiwara N,Kawasaki H,Yabe R,et al.A potential therapeutic application of SET/I2PP2Ainhibitor OP449for canine T-cell lymphoma[J].J Vet Med Sci,2013,75(3):349-354.
  • 7Cao L,Zhou J,Zhang J,et al.Cyclin-dependent kinase 5decreases in gastric cancer and its nuclear accumulation suppresses gastric tumorigenesis[J].Clin Cancer Res,2015,21(6):1419-1428.
  • 8Florou D,Patsis C,Ardavanis A,et al.Effect of doxorubicin,oxaliplatin,and methotrexate administration on the transcriptional activity of BCL-2family gene members in stomach cancer cells[J].Cancer Biol Ther,2013,14(7):587-596.
  • 9Li Y,Zhou Y,Zheng J,et al.Downregulation of survivin inhibits proliferation and migration of human gastric carcinoma cells[J].Int J Clin Exp Pathol,2015,8(2):1731-1736.
  • 10Han G,Gong H,Wang Y,et al.AMPK/mTOR-mediated inhibition of survivin partly contributes to metformin-induced apoptosis in human gastric cancer cell[J].Cancer Biol Ther,2015,16(1):77-87.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部